IL17A and influenza: To further see whether exogenous IL-17A would be sufficient to rescue influenza-infected WT mice challenged secondarily with S. pneumoniae, WT mice after influenza infection were treated with recombinant IL-17A protein and then challenged with S. pneumoniae.